Gisele Dion - Sep 1, 2022 Form 3 Insider Report for Inhibikase Therapeutics, Inc. (IKT)

Role
Director
Signature
/s/ Milton H. Werner, Attorney-In-Fact
Stock symbol
IKT
Transactions as of
Sep 1, 2022
Transactions value $
$0
Form type
3
Date filed
9/6/2022, 05:06 PM
Previous filing
Jun 3, 2022
Next filing
Jun 16, 2023

No securities are beneficially owned.

Remarks:

Remarks: Exhibit List: Exhibit 24 - Power of Attorney